95
Views
11
CrossRef citations to date
0
Altmetric
Original Article

Ultrastructure of Human Uterine Epithelium at the Time of Implantation after Postovulatory Administration of Norethindrone

&
Pages 65-71 | Received 23 Dec 1973, Published online: 18 Jan 2010
 

Abstract

The present investigation was performed to elucidate the mechanism of action of the previously demonstrated contraceptive effect in women of postovulatory administration of a synthetic gestagen, norethindrone (NET). Seven women participated during 3 control cycles and during 8 treatment cycles, in which NET was given orally after ovulation. Daily peripheral plasma levels of progesterone, estradiol and NET were assayed. An endometrial biopsy was taken in all cycles at about the expected time of implantation. Light microscopy revealed no consistent differences between non-treatment and treatment cycles but electron microscopy indicated that, after NET treatment, the mitochondria had grown larger and that nucleolar channel system had appeared. These changes suggest an increased progesterone-like influence upon the epithelium, despite the decreased progesterone plasma levels, caused by NET. It is assumed that these structural changes, caused by the postovulatory NET treatment, might change the functional properties of the endometrium and thereby impair the possibilities for normal implantation.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.